The Role of Geftinat in Non Small Cell Lung Cancer Induced by Autophagy
XU Zhi-hon
Abstract
XU Zhi-hon
Abstract
Objective: To observe The role of Geftinat in non small cell lung cancer induced by autophagy and to investigate the mechanism. Methods: 40 nude mice were randomly divided into two groups, the group with geftinat was treated by infusing the stomach with the medicine, 25mg/kg. The expression of Beclin1 and MAPLC3 were determined by immunofluorescence, RT-PCR and Western blot. Results: The Mrna and protein level of Beclin1 and MAPLC3 in the group with geftinat treating were both significant higher by immunofluorescence, RT-PCR and Western blot. Conclusion: Geftinat can inhibit the progress of non small cell lung cancer by influence autophagy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe The role of Geftinat in non small cell lung cancer induced by autophagy and to investigate the mechanism. Methods: 40 nude mice were randomly divided into two groups, the group with geftinat was treated by infusing the stomach with the medicine, 25mg/kg. The expression of Beclin1 and MAPLC3 were determined by immunofluorescence, RT-PCR and Western blot. Results: The Mrna and protein level of Beclin1 and MAPLC3 in the group with geftinat treating were both significant higher by immunofluorescence, RT-PCR and Western blot. Conclusion: Geftinat can inhibit the progress of non small cell lung cancer by influence autophagy.
Key concepts: Western blot, Autophagy, Immunofluorescence, Lung cancer, Cell, Blot, Lung, Cancer research